RAAG12

09/01/2009 - "RAAG12 exhibited differential subcellular localization in these normal, compared with tumor, tissues. "
09/01/2009 - "Immunohistochemistry of 36 normal human tissues and a broad range of tumor tissues to profile RAAG12 expression. "
09/01/2009 - "To determine the expression pattern of RAAG12 in normal and tumor tissue to identify indications for clinical study and potential safety issues. "
03/01/2007 - "More than 90% of tumors of colorectal, gastric, and pancreatic origin express RAAG12, and a majority of these tumors exhibit uniform RAAG12 expression. "
09/01/2009 - "High expression of RAAG12 on tumors of gastrointestinal origin suggests these cancers are appropriate targets for RAV12 therapy. "

03/01/2010 - "RAAG12 is highly expressed on many adenocarcinomas, particularly those of gastrointestinal origin. "
09/01/2009 - "More than 90% of colon, gastric, and pancreatic adenocarcinomas expressed RAAG12, and expression was uniform in most samples. "
09/01/2009 - "Expression of RAAG12 at lower frequency and/or uniformity was observed in other cancers, including esophageal, ovarian, liver, breast, and prostate carcinomas and adenocarcinomas. "

09/01/2009 - "Similar RAAG12 expression was observed between primary and metastatic colon adenocarcinomas. "

09/01/2009 - "Expression of RAAG12 at lower frequency and/or uniformity was observed in other cancers, including esophageal, ovarian, liver, breast, and prostate carcinomas and adenocarcinomas. "